Literature DB >> 25227655

De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU.

Jean-Francois Timsit1, Stephan Harbarth, Jean Carlet.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25227655     DOI： 10.1007/s00134-014-3485-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

1.  An antibiotic policy to prevent emergence of resistant bacilli.

Authors:  P de Man; B A Verhoeven; H A Verbrugh; M C Vos; J N van den Anker
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

3.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

Review 4.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.

Authors:  Pierre Fournier; Carole Schwebel; Danièle Maubon; Aurélien Vesin; Bernadette Lebeau; Luc Foroni; Rebecca Hamidfar-Roy; Muriel Cornet; Jean-François Timsit; Hervé Pelloux
Journal:  J Antimicrob Chemother       Date:  2011-10-06       Impact factor: 5.790

6.  Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.

Authors:  Alexis Tabah; Despoina Koulenti; Kevin Laupland; Benoit Misset; Jordi Valles; Frederico Bruzzi de Carvalho; José Artur Paiva; Nahit Cakar; Xiaochun Ma; Philippe Eggimann; Massimo Antonelli; Marc J M Bonten; Akos Csomos; Wolfgang A Krueger; Adam Mikstacki; Jeffrey Lipman; Pieter Depuydt; Aurélien Vesin; Maité Garrouste-Orgeas; Jean-Ralph Zahar; Stijn Blot; Jean Carlet; Christian Brun-Buisson; Claude Martin; Jordi Rello; Georges Dimopoulos; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2012-09-26       Impact factor: 17.440

7.  Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.

Authors:  Laurence Armand-Lefèvre; Cécile Angebault; François Barbier; Emilie Hamelet; Gilles Defrance; Etienne Ruppé; Régis Bronchard; Raphaël Lepeule; Jean-Christophe Lucet; Assiya El Mniai; Michel Wolff; Philippe Montravers; Patrick Plésiat; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

8.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.

Authors:  J J Rahal; C Urban; D Horn; K Freeman; S Segal-Maurer; J Maurer; N Mariano; S Marks; J M Burns; D Dominick; M Lim
Journal:  JAMA       Date:  1998-10-14       Impact factor: 56.272

9.  Antibiotic consumption and resistance: data from Europe and Germany.

Authors:  Elisabeth Meyer; Petra Gastmeier; Maria Deja; Frank Schwab
Journal:  Int J Med Microbiol       Date:  2013-04-29       Impact factor: 3.473

10.  Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity.

Authors:  Elisabeth Paramythiotou; Jean-Christophe Lucet; Jean-François Timsit; Dominique Vanjak; Catherine Paugam-Burtz; Jean-Louis Trouillet; Stéphanie Belloc; Najiby Kassis; Andreas Karabinis; Antoine Andremont
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079
View more
  16 in total

1.  Understanding antibiotic stewardship for the critically ill.

Authors:  J J De Waele; J Schouten; G Dimopoulos
Journal:  Intensive Care Med       Date:  2015-08-20       Impact factor: 17.440

2.  Does this patient have VAP?

Authors:  Jean Chastre; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2016-02-03       Impact factor: 17.440

3.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

4.  If antibiotics did not exist.

Authors:  Marin H Kollef; Cristina Vazquez Guillamet
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

5.  Ten tips on how to win the war against resistance to antibiotics.

Authors:  Jean Carlet
Journal:  Intensive Care Med       Date:  2015-01-09       Impact factor: 17.440

6.  Antipathy against SDD is justified: Yes.

Authors:  Jean-François Timsit; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2018-06-07       Impact factor: 17.440

Review 7.  Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.

Authors:  Werner C Albrich; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2015-07-21       Impact factor: 17.440

8.  A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients.

Authors:  Mieke Carlier; Jason A Roberts; Veronique Stove; Alain G Verstraete; Jeffrey Lipman; Jan J De Waele
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

9.  Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.

Authors:  Philippe Montravers; Pascal Augustin; Nathalie Grall; Mathieu Desmard; Nicolas Allou; Jean-Pierre Marmuse; Jean Guglielminotti
Journal:  Crit Care       Date:  2016-04-07       Impact factor: 9.097

10.  How to measure the impacts of antibiotic resistance and antibiotic development on empiric therapy: new composite indices.

Authors:  Josie S Hughes; Amy Hurford; Rita L Finley; David M Patrick; Jianhong Wu; Andrew M Morris
Journal:  BMJ Open       Date:  2016-12-16       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.